Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
Tancin Lambert A, Ratajczak-Tretel B, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezai MK, Rørholt DM, Steffensen LH, Sømark J, Tobro H, Truelsen TC, Wassvik L, AEgidius KL, Pesonen M, de Melis M, Atar D, Aamodt AH; NOR-FIB Study Group. Tancin Lambert A, et al. Among authors: novotny v. Eur J Neurol. 2023 May;30(5):1352-1363. doi: 10.1111/ene.15746. Epub 2023 Mar 10. Eur J Neurol. 2023. PMID: 36786305
Time patterns in multiple acute cerebral infarcts.
Novotny V, Khanevski AN, Thomassen L, Waje-Andreassen U, Naess H. Novotny V, et al. Int J Stroke. 2017 Dec;12(9):969-975. doi: 10.1177/1747493016677979. Epub 2016 Nov 3. Int J Stroke. 2017. PMID: 27811310
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Rønning OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, Tobro H, Kaur K, Stankiewicz M, Carlsson M, Morsund Å, Idicula T, Aamodt AH, Lund C, Næss H, Waje-Andreassen U, Thomassen L. Logallo N, et al. Among authors: novotny v. Lancet Neurol. 2017 Oct;16(10):781-788. doi: 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2. Lancet Neurol. 2017. PMID: 28780236 Clinical Trial.
Thirty-day recurrence after ischemic stroke or TIA.
Khanevski AN, Bjerkreim AT, Novotny V, Naess H, Thomassen L, Logallo N, Kvistad CE. Khanevski AN, et al. Among authors: novotny v. Brain Behav. 2018 Oct;8(10):e01108. doi: 10.1002/brb3.1108. Epub 2018 Sep 17. Brain Behav. 2018. PMID: 30222913 Free PMC article.
Recurrent ischemic stroke: Incidence, predictors, and impact on mortality.
Khanevski AN, Bjerkreim AT, Novotny V, Naess H, Thomassen L, Logallo N, Kvistad CE; NOR-STROKE study group. Khanevski AN, et al. Among authors: novotny v. Acta Neurol Scand. 2019 Jul;140(1):3-8. doi: 10.1111/ane.13093. Epub 2019 Apr 11. Acta Neurol Scand. 2019. PMID: 30929256 Free PMC article.
Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke.
Kvistad CE, Novotny V, Kurz MW, Rønning OM, Thommessen B, Carlsson M, Waje-Andreassen U, Næss H, Thomassen L, Logallo N. Kvistad CE, et al. Among authors: novotny v. Stroke. 2019 May;50(5):1279-1281. doi: 10.1161/STROKEAHA.119.025041. Stroke. 2019. PMID: 31009339 Clinical Trial.
323 results